How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?

Henderson, Wendy O; Parker, Mary H; Batch, Bryan C

Henderson, Wendy O; Parker, Mary H; Batch, Bryan C.

Afiliação

Henderson WO; Associate Chief of Staff, Ambulatory Care Service, Durham VA Health Care System; Assistant Professor, Department of Medicine, Duke University, Durham, NC.
Parker MH; Acting Chief Medical Officer, VA Mid-Atlantic Health Care Network (VISN6); Clinical Coordinator/Clinical Pharmacy Specialist, Pharmacy and Ambulatory Care, Durham VA Health Care System, Durham, NC mary.h.parker@gmail.com.
Batch BC; Endocrine Section Chief, Durham VA Health Care System; Associate Professor of Medicine, Duke University Division of Endocrinology, Durham, NC.

Cleve Clin J Med ; 88(2): 81-85, 2021 02 01.

Article em En | MEDLINE | ID: mdl-33526460

Assuntos

Diabetes Mellitus Tipo 2; Controle Glicêmico; Glicemia; Diabetes Mellitus Tipo 2/tratamento farmacológico; Hemoglobinas Glicadas/análise; Testes Hematológicos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Controle Glicêmico Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google